Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/34195
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Peynirci, Hande | - |
dc.contributor.author | Taşkıran, Bengür | - |
dc.date.accessioned | 2023-10-04T08:12:54Z | - |
dc.date.available | 2023-10-04T08:12:54Z | - |
dc.date.issued | 2018-06 | - |
dc.identifier.citation | Peynirci, H. vd. (2018). ''Is parenteral levothyroxine therapy safe in intractable hypothyroidism?''. Journal of the National Medical Association, 110(3), 245-249. | en_US |
dc.identifier.issn | 0027-9684 | - |
dc.identifier.issn | 1943-4693 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jnma.2017.05.007 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/S0027968417300287 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34195 | - |
dc.description.abstract | Case: A 32-year old woman was admitted to the hospital due to intractable hypothyroidism refractory to high dose of oral L-thyroxine therapy. She underwent total thyroidectomy and radioactive iodine therapy due to papillary thyroid cancer. After excluding poor adherence to therapy and malabsorption, levothyroxine absorption test was performed. No response was detected. Transient neurologic symptoms developed during the test. She developed 3 attacks consisting of neurologic symptoms during high dose administration. The patient was considered a case of isolated L-thyroxine malabsorption. She became euthyroid after intramuscular twice weekly L-thyroxine therapy. Discussion: There are a few case reports regarding isolated L-thyroxine. We report successful long term results of twice weekly administered intramuscular L-thyroxine therapy. We also draw attention to neurologic side effects of high dose L-thyroxine therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Natl Med Assoc | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | General & internal medicine | en_US |
dc.subject | Hypothyroidism | en_US |
dc.subject | Levothyroxine | en_US |
dc.subject | Malabsorption | en_US |
dc.subject | Neurologic manifestations | en_US |
dc.subject | Thyroxine absorption | en_US |
dc.subject | Pseudomalabsorption | en_US |
dc.subject | Malabsorption | en_US |
dc.subject | Replacement | en_US |
dc.subject | Patient | en_US |
dc.subject | Disease | en_US |
dc.subject.mesh | Administration, oral | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypothyroidism | en_US |
dc.subject.mesh | Injections, intramuscular | en_US |
dc.subject.mesh | Intestinal absorption | en_US |
dc.subject.mesh | Malabsorption syndromes | en_US |
dc.subject.mesh | Thyroid cancer, papillary | en_US |
dc.subject.mesh | Thyroid neoplasms | en_US |
dc.subject.mesh | Thyroidectomy | en_US |
dc.subject.mesh | Thyroxine | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.title | Is parenteral levothyroxine therapy safe in intractable hypothyroidism? | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000432909100008 | tr_TR |
dc.identifier.scopus | 2-s2.0-85020916109 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolik Bozukluklar Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 245 | tr_TR |
dc.identifier.endpage | 249 | tr_TR |
dc.identifier.volume | 110 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Journal of the National Medical Association | en_US |
dc.contributor.buuauthor | Ertürk, Erdinç | - |
dc.contributor.buuauthor | Şişman, Pınar | - |
dc.contributor.buuauthor | Ersoy, Canan | - |
dc.contributor.researcherid | AAJ-6536-2021 | tr_TR |
dc.contributor.researcherid | AAH-8861-2021 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 29778126 | tr_TR |
dc.subject.wos | Medicine, general & internal | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 7005488796 | tr_TR |
dc.contributor.scopusid | 57190169474 | tr_TR |
dc.contributor.scopusid | 6701485882 | tr_TR |
dc.subject.scopus | Levothyroxine Sodium; Hypothyroidism; Thyrotropin | en_US |
dc.subject.emtree | Acetylsalicylic acid | en_US |
dc.subject.emtree | Levothyroxine | en_US |
dc.subject.emtree | Liothyronine | en_US |
dc.subject.emtree | Thyrotropin | en_US |
dc.subject.emtree | Thyroxine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aphasia | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Body mass | en_US |
dc.subject.emtree | Body temperature | en_US |
dc.subject.emtree | Body weight gain | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Drug megadose | en_US |
dc.subject.emtree | Drug safety | en_US |
dc.subject.emtree | Dry skin | en_US |
dc.subject.emtree | Fatigue | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Free thyroxine index | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Hemiparesis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypertension | en_US |
dc.subject.emtree | Hypothyroidism | en_US |
dc.subject.emtree | Menstruation | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Thyroid function test | en_US |
dc.subject.emtree | Thyrotropin blood level | en_US |
dc.subject.emtree | Transient ischemic attack | en_US |
dc.subject.emtree | Treatment response | en_US |
dc.subject.emtree | Visual impairment | en_US |
dc.subject.emtree | Hypothyroidism | en_US |
dc.subject.emtree | Intestine absorption | en_US |
dc.subject.emtree | Intramuscular drug administration | en_US |
dc.subject.emtree | Malabsorption | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Oral drug administration | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Procedures | en_US |
dc.subject.emtree | Thyroid tumor | en_US |
dc.subject.emtree | Thyroidectomy | en_US |
dc.subject.emtree | Treatment outcome | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.